HEADER TOXIN 06-JAN-17 5UG3 TITLE NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN GID MUTANT A10V COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-CONOTOXIN GID; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: CONUS GEOGRAPHUS; SOURCE 4 ORGANISM_COMMON: GEOGRAPHY CONE; SOURCE 5 ORGANISM_TAXID: 6491 KEYWDS NEUROTOXIN, NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.K.HUSSEIN,A.E.LEFFLER,H.A.ZEBROSKI,S.R.POWELL,A.KURYATOV, AUTHOR 2 P.FILIPENKO,J.GORSON,A.HEIZMANN,S.LYSKOV,A.NICKE,J.LINDSTROM,B.RUDY, AUTHOR 3 R.BONNEAU,M.HOLFORD,S.F.POGET REVDAT 6 14-JUN-23 5UG3 1 REMARK REVDAT 5 04-DEC-19 5UG3 1 REMARK REVDAT 4 27-NOV-19 5UG3 1 REMARK REVDAT 3 04-OCT-17 5UG3 1 JRNL REVDAT 2 20-SEP-17 5UG3 1 JRNL REVDAT 1 06-SEP-17 5UG3 0 JRNL AUTH A.E.LEFFLER,A.KURYATOV,H.A.ZEBROSKI,S.R.POWELL,P.FILIPENKO, JRNL AUTH 2 A.K.HUSSEIN,J.GORSON,A.HEIZMANN,S.LYSKOV,R.W.TSIEN, JRNL AUTH 3 S.F.POGET,A.NICKE,J.LINDSTROM,B.RUDY,R.BONNEAU,M.HOLFORD JRNL TITL DISCOVERY OF PEPTIDE LIGANDS THROUGH DOCKING AND VIRTUAL JRNL TITL 2 SCREENING AT NICOTINIC ACETYLCHOLINE RECEPTOR HOMOLOGY JRNL TITL 3 MODELS. JRNL REF PROC. NATL. ACAD. SCI. V. 114 E8100 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28874590 JRNL DOI 10.1073/PNAS.1703952114 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UG3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225655. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 280 REMARK 210 PH : 3 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.5 MM A10V DESIGN 5 MUTANT, REMARK 210 100% D2O; 1.5 MM A10V DESIGN 5 REMARK 210 MUTANT, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D DQF-COSY; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR, ARIA, NMRPIPE, VNMR, REMARK 210 TOPSPIN, CNS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 2 47.85 -172.85 REMARK 500 1 HIS A 17 45.22 -163.89 REMARK 500 2 HYP A 16 93.06 -61.36 REMARK 500 3 HYP A 16 47.73 -76.73 REMARK 500 3 HIS A 17 27.98 -165.67 REMARK 500 3 VAL A 18 76.81 -114.08 REMARK 500 4 HYP A 16 59.00 -69.35 REMARK 500 4 HIS A 17 -47.90 75.29 REMARK 500 4 VAL A 18 -52.44 70.43 REMARK 500 5 ASP A 3 41.02 -109.72 REMARK 500 6 HYP A 16 -79.71 -67.64 REMARK 500 6 HIS A 17 48.50 -147.29 REMARK 500 7 HYP A 16 39.69 -79.15 REMARK 500 7 HIS A 17 18.32 -144.41 REMARK 500 8 HYP A 16 -75.97 -66.15 REMARK 500 8 HIS A 17 46.82 -148.36 REMARK 500 9 ARG A 2 68.26 -113.24 REMARK 500 10 HIS A 17 49.38 -154.14 REMARK 500 11 ASP A 3 50.18 -94.14 REMARK 500 11 HYP A 16 49.54 -73.70 REMARK 500 13 ARG A 2 47.71 -160.18 REMARK 500 13 HYP A 16 48.83 -72.54 REMARK 500 14 ASP A 3 40.73 -101.29 REMARK 500 14 HYP A 16 39.16 -81.88 REMARK 500 14 HIS A 17 13.36 -147.24 REMARK 500 15 HYP A 16 42.61 -77.24 REMARK 500 15 HIS A 17 28.04 -166.86 REMARK 500 16 ARG A 2 173.77 64.94 REMARK 500 16 HIS A 17 55.81 -159.76 REMARK 500 17 HYP A 16 35.33 -78.52 REMARK 500 17 HIS A 17 30.98 -150.13 REMARK 500 18 ASP A 3 -165.74 -106.22 REMARK 500 19 ARG A 2 77.14 -152.00 REMARK 500 19 HIS A 17 39.82 -156.93 REMARK 500 19 VAL A 18 -73.59 -82.63 REMARK 500 20 ASP A 3 30.79 -98.49 REMARK 500 20 HYP A 16 37.09 -79.56 REMARK 500 20 VAL A 18 -33.40 -157.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30225 RELATED DB: BMRB REMARK 900 NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN GID MUTANT A10V REMARK 900 RELATED ID: 5UG5 RELATED DB: PDB DBREF 5UG3 A 1 19 UNP P60274 CA1D_CONGE 1 19 SEQADV 5UG3 VAL A 10 UNP P60274 ALA 10 ENGINEERED MUTATION SEQRES 1 A 19 ILE ARG ASP GLU CYS CYS SER ASN PRO VAL CYS ARG VAL SEQRES 2 A 19 ASN ASN HYP HIS VAL CYS MODRES 5UG3 HYP A 16 PRO MODIFIED RESIDUE HET HYP A 16 15 HETNAM HYP 4-HYDROXYPROLINE HETSYN HYP HYDROXYPROLINE FORMUL 1 HYP C5 H9 N O3 HELIX 1 AA1 ASP A 3 SER A 7 5 5 HELIX 2 AA2 ASN A 8 ASN A 15 1 8 SSBOND 1 CYS A 5 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 6 CYS A 19 1555 1555 2.03 LINK C ASN A 15 N HYP A 16 1555 1555 1.33 LINK C HYP A 16 N HIS A 17 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1